Target
Serine/threonine-protein kinase 17B
Ligand
BDBM441905
Substrate
n/a
Meas. Tech.
Activity Inhibition Assay
IC50
410±n/a nM
Citation
 Lee, KChoi, GLee, NRPark, SJJung, MEKim, SJYang, KLee, J Substituted pyrimidines for preventing or treating cancer and inflammatory diseases US Patent  US10647686 Publication Date 5/12/2020 
Target
Name:
Serine/threonine-protein kinase 17B
Synonyms:
DRAK2 | ST17B_HUMAN | STK17B | Serine/threonine-protein kinase 17B | Serine/threonine-protein kinase 17B (STK17B)
Type:
Enzyme
Mol. Mass.:
42332.49
Organism:
Homo sapiens (Human)
Description:
O94768
Residue:
372
Sequence:
MSRRRFDCRSISGLLTTTPQIPIKMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSSCNGTCGDREDKENIPEDSSMVSKRFRFDDSLPNPHELVSDLLC
  
Inhibitor
Name:
BDBM441905
Synonyms:
US10647686, Example 1
Type:
Small organic molecule
Emp. Form.:
C12H18Cl2N4O2
Mol. Mass.:
321.203
SMILES:
CC(C)(C)OC(=O)NCCCNc1nc(Cl)ncc1Cl
Structure:
Search PDB for entries with ligand similarity: